Salivaricin 9 (Sal9) is a 2560 Da lantibiotic having just 46 % amino acid identity with its closest known homologue, the Streptococcus pyogenes lantibiotic SA-FF22. The Sal9 locus (designated siv) in Streptococcus salivarius strain 9 was partially sequenced and localized to an approximately 170 kb megaplasmid, which also harbours the locus for the lantibiotic salivaricin A4. The entire locus was fully characterized in the draft genome sequence of S. salivarius strain JIM8780 and shown to consist of eight genes, having the following putative functions: sivK, sensor kinase; sivR, response regulator; sivA, Sal9 precursor peptide; sivM, lantibiotic modification enzyme; sivT, ABC transporter involved in the export of Sal9 and concomitant cleavage of its leader peptide; and sivFEG, encoding lantibiotic self-immunity. Intriguingly, in contrast to strain 9, the siv locus was chromosomally located in strain JIM8780 -the first lantibiotic locus shown not to be exclusively plasmid-associated in S. salivarius. Sal9-containing extracts specifically induced lantibiotic production in both strain 9 and strain JIM8780, indicating that Sal9 functions as a signal peptide for upregulation of its own biosynthesis. Screening representative strains of three streptococcal species (S. salivarius, S. pyogenes and S. mitis) for sivA indicated that it was present only in S. salivarius, with 12 of 28 tested S. salivarius positive. Since Sal9 was inhibitory to all tested S. pyogenes strains it appears to have potential as an important component of the bacteriocin armoury of S. salivarius probiotics intended to control S. pyogenes infections of the human oral cavity.
INTRODUCTION
Lantibiotics are ribosomally synthesized antimicrobial peptides that contain characteristic post-translational modifications, typified by the thioether amino acids lanthionine and methyllanthionine, from which the name lantibiotic is derived (Chatterjee et al., 2005; Jung, 1991; Schnell et al., 1988) . Approximately 50 lantibiotics have been shown to be produced by Gram-positive bacteria (Patton & van der Donk, 2005) , and nisin, the prototype lantibiotic, has been used as a food preservative for more than 40 years (Chatterjee et al., 2005) . Other lantibiotics are also beginning to find commercial outlets, such as the proposed use of lacticin 3147 for the prevention and treatment of mastitis in dairy cattle (Twomey et al., 2000) .
An indirect application of lantibiotics stems from their production by some probiotic bacteria . For example, it has been observed that the natural occurrence in the human oral cavity of Streptococcus salivarius populations producing bacteriocin-like inhibitory substances (BLIS) correlates with decreased rates of acquisition of the pathogen Streptococcus pyogenes (Dierksen & Tagg, 2000; Fantinato et al., 1999) . S. salivarius K12, the first widely used oral probiotic, has been shown to produce two lantibiotics, salivaricin A2 (SalA2) and salivaricin B (SalB) (Hyink et al., 2007) . Other lantibiotic loci have also been identified in S. salivarius, including those encoding (a) salivaricin A (SalA) (Ross et al., 1993) and its natural variants salivaricin A3, salivaricin A4 and salivaricin A5 , (b) salivaricin G32, which differs from the S. pyogenes lantibiotic SA-FF22 propeptide by just one amino acid (Wescombe, 2002) , and (c) streptin, which is also commonly produced by S. pyogenes strains (Wescombe et al., 2006a) . The SalA cluster of lantibiotics and streptin have all been shown to act as auto-inducer peptides -being recognized by specific two-component sensor-kinase/response-regulator systems, which serve to upregulate transcription of the lantibiotic structural gene and thereby effect increased lantibiotic production (Upton et al., 2001; Wescombe & Tagg, 2003) .
In our initial studies of S. salivarius BLIS, strain 9 was one of six prototype inhibitory strains identified (Dempster & Tagg, 1982) . The inhibitory activity of strain 9 was shown to be due, at least in part, to the production of SalA4 (a natural variant of SalA) . However, it soon became clear that SalA4 does not account for the entire inhibitory activity of strain 9. The present study reports the genetic basis for and peptide identity of salivaricin 9 (Sal9), a novel lantibiotic, the genetic locus of which in S. salivarius can be either chromosomal or megaplasmid-located.
METHODS
Bacterial strains and culture conditions. All strains were propagated on Columbia blood agar base (Difco) supplemented with 5 % human blood (BaCa) by incubation in 5 % CO 2 in air at 37 uC. Other media included M17 (Difco) supplemented with 0.5 % sucrose, Todd-Hewitt broth (THB) (Difco) and THB supplemented with CaCO 3 (4 mmol l 21 ) and glucose (0.1 %, w/v) (THBCaGlu). The principal test strains used in the present study were S. salivarius strain 9 (one of the originally described S. salivarius bacteriocin producer strains) (Dempster & Tagg, 1982) , JIM8780 (Delorme et al., 2007) and M18 (also known as Mia) (Wescombe et al., 2006a) . Other details of the strains are listed in Tables 1 and 2 .
Deferred antagonism assays. The method of deferred antagonism originally described by Tagg & Bannister (1979) was used either to determine the producer-type (P-type) of BLIS activity of the test strains, or to compare the relative susceptibilities of different bacterial strains to the BLIS activities produced in agar media and to determine the activity Kelstrup (1981) *Plasmid-cured derivatives of the parent strain.
Characterization of the lantibiotic salivaricin 9 spectrum of Sal9 producers. Briefly, the test strain was inoculated diametrically across the surface of the BaCa medium as a 1 cm-wide streak. After incubation, the test strain growth was removed using a glass slide and the surface of the agar sterilized by exposure to chloroform vapour for 30 min. The plate was then aired for 15 min before 18 h THB cultures of the indicator strains were inoculated across the line of the original producer growth. The plates were then incubated as before for 24 h and examined for zones of interference with the indicator growth. In order to establish the P-type designation, the inhibitory activity against the nine standard indicators was recorded in code form (the Ptype) by considering the indicators as three triplets (i.e. I1, I2, I3; I4, I5, I6; and I7, I8, I9). Inhibition of the first member of a triplet was given a score of 4, the second a score of 2, and the third a score of 1. Absence of inhibitor action against an indicator was scored as 0. The P-type code was then recorded as a sequence of three numbers representing the sum of each triplet. All tests were performed in duplicate, and further testing was undertaken until consistency of the inhibition patterns was obtained. ] of the inhibitory activity in the original test preparation was defined as the reciprocal of the highest dilution of a doubling dilution series to inhibit the growth of the indicator lawn.
PCR amplification of siv and sal genes. The nucleotide sequences of several different examples of each of the lantibiotic modifying genes (i.e. lanM, lanB and lanC) have previously (Hyink et al., 2005; Wirawan et al., 2006) been used to design the following degenerate PCR primer sets: LanM-fwd, 59-ATGCWAGWYWTGCWCATGG-39, and LanM-rev, 59-CCTAATGAACCRTRRYAYCA-39; LanB-fwd, 59-TATGATCGAGAARYAKAWAGATATGG-39, and LanB-rev, 59-TTATTAIRCAIATGIAYDAWACT-39; LanC-fwd, 59-TAATTTAGG-ATWISYIMAYGG-39, and LanC-rev, 59-ACCWGKIIIICCRTRRCA-CCA-39. These primers were utilized in the present study to amplify putative lantibiotic loci in strain 9. All amplifications were carried out using Hotmaster Taq polymerase (Eppendorf). Typical PCRs for the degenerate primer sets included 41.5 ml PCR-quality water (Eppendorf), 5 ml 106 Buffer (Hotmaster, Eppendorf), 1 ml nucleotide mix (Roche), 1 ml each of the appropriate forward and reverse primers (primer stocks at 0.1 ng ml 21 for the lantibiotic degenerate primers or 0.01 ng ml 21 for standard PCR) and 0.5 ml Taq (Hotmaster, 5 U ml
21
). An initial denaturation at 95 uC was carried out for 2 min followed by 30 cycles of 95 uC for 30 s, annealing at 40 uC (for the degenerate lantibiotic primers) or 55 uC (for sivA or salA amplification) for 30 s and elongation for 1 min at 65 uC. Two per cent agarose gels were run to analyse all PCR products. For the 'universal' lantibiotic amplifications, DNA bands that were of similar size to the control reactions were gel extracted (Qiagen gel extraction kit) and cloned into pGEM-T (Promega) according to the manufacturer's instructions, then sequenced. Inverse PCR techniques were used to amplify the regions outside the modification gene and to obtain sequence for the lantibiotic structural gene(s) (Triglia et al., 1988) .
Identification of the locus encoding Sal9. When the draft genome sequence of S. salivarius strain JIM8780 (P. Renault, unpublished data) was examined for sivA homologues, a locus containing eight genes, including sivA, was identified. The locus was characterized by a combination of BLASTN, BLASTX and BLASTP searches against the GenBank database using search engines at the National Center for Biotechnology Information (NCBI; http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Megaplasmid detection using pulsed-field gel electrophoresis (PFGE). Using previously described methods (Wescombe et al., 2006a) , PFGE was used to detect the megaplasmid DNA content of the test strains 9, K12 and JH (PFGE examination of strain JIM8780 failed repeatedly due to apparent autodigestion of the DNA). One millilitre of 18 h Todd-Hewitt Broth (THB) cultures of the test strains was used to inoculate 20 ml THB cultures, which in turn were incubated at 37 uC in 5 % CO 2 in air until reaching an optical density (650 nm) of 0.5. The cells were then embedded in low-melting-point agarose (SeaPlaque, FMC BioProducts) and lysed using 40 mg lysozyme ml 21 (Roche), followed by treatment with proteinase K (1 mg ml 21 ) (Sigma). The proteinase K was removed by six 1 h TE (10 mM Tris, 1 mM EDTA, pH 7.5) washes with shaking (120 r.p.m.) at room temperature. After digestion with SmaI, the DNA was separated using a CHEF-DR III Pulsed Field Electrophoresis System (Bio-Rad) over 20-23 h in a 1 % agarose gel (Pulsed Field Certified Agarose, Bio-Rad). An initial pulse time of 6 s and final of 18 s were used. The included angle (change in orientation of the field) was 120u, and the gel was run at 4.5 V cm 21 with the buffer maintained at 14 uC. Gels were stained with ethidium bromide (5 mg ml
) and examined by UV transillumination.
Localization of the siv locus using Southern blotting and DNA probing. DNA from PFGE was transferred to Hybond-N+ nylon membranes (Amersham Biosciences) using a VACUGENE 2016 vacuum blotting unit (Pharmacia LKB Biotechnology) and fixed to the membrane by exposure to 0.4 M NaOH for 20 min. Probes for hybridization were generated using (a) the sivA primers sivF (59-AAAAAGGCGCTTCTATATCCATGA-39) and sivR (59-ATCTTT-ACCTCAAACTTTTAAGTCCATT-39) and (b) the salA primers salAF (59-GATATTTTGAACAATGCTATCGAAG-39) and salAR (59-ACTAATAGAAGTATCTAGTATGTCG-39). The amplification parameters were 30 cycles of 95 uC for 30 s, annealing at 55 uC for 30 s and elongation of 1 min at 65 uC. Radiolabelling was done by use of the Ready-To-Go DNA Labelling Beads (dCTP) kit (Amersham Biosciences). These probes were used to localize the lantibiotic loci on PFGE blots by autoradiography.
Purification of Sal9. S. salivarius strain 9 typically produces only very small quantities of bacteriocin when grown in liquid cultures. To overcome this problem, a method was devised to obtain enhanced (induced) bacteriocin production by supplementing the growing strain 9 cultures with pre-formed Sal9. Inducer preparations of Sal9 were prepared by growing S. salivarius strain 9 lawn cultures for 18 h at 37 uC in 5 % CO 2 in air on M17 agar supplemented with 0.5 % sucrose. The agar culture was then frozen at 270 uC and subsequently thawed. The exudate fluid was collected and assayed for inhibitory activity against M. luteus using the 20 ml spot assay. One hundred microlitres of preparations of titre greater than 2 was added per 10 ml of THB freshly inoculated (1 %, v/v) from an 18 h THB culture of strain 9. This achieved enhanced (induced) production of Sal9 during the subsequent growth at 37 uC for 18 h in 5 % CO 2 in air. It was found that when the cells from each 10 ml culture were harvested by centrifugation (10 300 g for 10 min), resuspended in 1 ml 95 % methanol containing 25 mmol HCl l 21 and incubated for 18 h at 4 uC, a relatively pure bacteriocin preparation could be obtained when compared to that from the culture supernatants. After removing the cells by centrifugation, the bacteriocin-containing supernatant was concentrated 10-fold by evaporation under vacuum using a Speedvac centrifuge (Eppendorf), then fractionated by HPLC on a C18 reversed-phase column (Phenomenex Jupiter C18 column, 5 mm, 300 Å , 25064.6 mm) using a gradient of 20 to 50 % acetonitrile over 50 min and a flow rate of 1 ml min 21 . Fractions having inhibitory activity against M. luteus were further analysed by matrix-assisted Fig. 1 . Schematic of the Sal9 locus in S. salivarius strain JIM8780 and the corresponding insertion region in the chromosome of JIM8777. The region for which DNA sequence was obtained from strain 9 is shown by the dashed line. The black arrows represent truncated transposase genes and dashed oblongs are traces of genes of unknown functions. Proposed functions for each gene in the Sal9 locus are as follows: sivK, putative sensor kinase; sivR, putative response regulator; sivA, Sal9 precursor peptide; sivM, putative lantibiotic modification enzyme; sivT, putative ABC transporter involved in the export of Sal9 and concomitant cleavage of its leader peptide; and sivFEG, encoding lantibiotic self-immunity. (Hubbard & McHugh, 1996) .
Induction of BLIS production in S. salivarius strains 9, JIM8780 and 20P3. The specificity of the bacteriocin-inducing activities present in crude extracts of S. salivarius strain 9 cultures and in HPLC-purified peptide fractions having anti-M. luteus activity was assessed using previously described methods . Briefly, 10 ml THB cultures of S. salivarius strains 9, JIM8780 and 20P3 were grown for 18 h at 37 uC in 5 % CO 2 in air. These cultures were centrifuged (15 300 g for 1 min) and the pellets washed three times in 10 ml volumes of 0.85 % NaCl (w/v) to reduce the levels of cell surface-associated lantibiotic/signal peptide. The cells were then resuspended in 10 ml 0.85 % NaCl. THBCaGlu (20 ml) was inoculated with 100 ml of washed cells, and 180 ml aliquots of this cell suspension were dispensed into wells in a microtitre plate. Six wells were used for each sample to be tested for SalA-or Sal9-inducing activity. Three wells in each set were designated as controls (i.e. uninduced) and three as tests. To each of the test wells, 10 ml of the test sample was added. After 18 h incubation at 37 uC in 5 % CO 2 in air, 10 ml of test sample was added to each of the three control wells. Samples (50 ml) from each of the test and control wells were then tested for inhibitory activity against indicator I1 using the agar well diffusion assay as described previously ). Induction of SalA or Sal9 production was demonstrated by the appearance of inhibitory zones surrounding the test wells, but not the corresponding control wells.
RESULTS AND DISCUSSION
Identification of a novel lantibiotic locus in S. salivarius strain 9
In the present study, PCR using a set of lanM-specific primers first detected the locus of a putative new member of the streptococcin A-FF22/lacticin 481 lantibiotic family (Dufour et al., 2007) in S. salivarius strain 9. Inverse PCR then extended the sequence beyond the lanM gene to identify 6277 bp encoding the corresponding structural gene and regulatory elements of the locus (Fig. 1) . The Sal9 propeptide is significantly different from its closest homologue, SA-FF22, having only 46 % identity at the amino acid level (11 out of 24 residues identical) (Fig. 2b) . Despite these differences, the thioether bridges within the propeptide are predicted to be conserved, indicating that they share similar molecular conformations (Fig. 2c) . Interestingly, the predicted propeptide of Sal9 contains no serine, making it the first member of the SA-FF22/lacticin 481 lantibiotic family to lack serine (Dufour et al., 2007) . A further distinguishing feature of Sal9 is that the predicted dehydro-residue (in this lantibiotic family characteristically situated directly adjacent to the C-terminal cysteine) is in Sal9 located 5 residues Nterminal to the cysteines (Fig. 2b) . While it is not at present clear whether this may affect the specific activity of the molecule, its novelty would encourage a site-directed mutagenesis approach to shed more light on the significance of this difference.
The DNA sequence obtained from strain 9 PCR products allowed identification of the entire Sal9 locus in the unpublished genome sequence of S. salivarius strain JIM8780. The Sal9 nucleotide sequences of strain 9 and strain JIM8780 share 98.9 % identity, with the predicted translation products having a mean identity of 98 % (range 97-99 %). The DNA sequence of the Sal9 locus includes: (a) sivK, encoding a putative sensor kinase, and sivR, the corresponding putative response regulator, which together are predicted to be involved in the regulation of Sal9 biosynthesis (Hyink et al., 2007; McLaughlin et al., 1999; Upton et al., 2001) ; (b) sivA, which encodes the Sal9 precursor peptide; (c) sivM, the gene encoding the putative lantibiotic modification enzyme; (d) sivT, having close homology with scnT (the SA-FF22 ABC transporter) and thought likely to encode an ABC transporter involved in the export of Sal9 and concomitant cleavage of its leader peptide; and (e) sivFEG, which corresponds to gene clusters typically involved in lantibiotic self-immunity (Fig. 1) . There is one predicted amino acid difference at position 10 of the Sal9 leader sequence, with serine present in strain JIM8780 and alanine in strain 9. Because this sequence is not highly conserved in other lantibiotic leaders (Fig. 2a) , it is not expected that this would result in a significant difference in either the peptide's post-translational processing or its transport from the cell.
The locus resembles that of a number of other lantibiotics of the lacticin 481 family, but is most similar to SA-FF22/macedocin loci (McLaughlin et al., 1999; Papadelli et al., 2007) . The degree of identity at the amino acid level of the translated gene products of the Sal9 locus with the equivalent gene products from SA-FF22 was determined by BLASTX analysis as: SivK/ScnK, 46 %; SivR/ScnR, 68 %; SivA/ScnA, 65 %; SivM/ScnM, 48 %; SivT/ScnT, 60 %; SivF/ScnF, 67 %; SivE/ScnE, 35 %; and SivG/ScnG, 45 %.
Megaplasmid localization of the Sal9 and SalA lantibiotic loci in S. salivarius strain 9
The Sal9 and SalA loci were localized to an approximately 170 kbp megaplasmid in strain 9 (Fig. 3) , bringing the number of megaplasmid-located lantibiotic loci in S. salivarius to five (Wescombe et al., 2006a) . Linear forms of megaplasmids were visualized in the undigested total DNA (lanes 2, 4 and 6 in Fig. 3d) as single faint bands. Only linear forms of megaplasmids migrate at rates that allow size determination by comparison with linear markers. Closed circular supercoiled forms move very slowly, and relaxed and nicked open circular forms remain trapped in the sample wells (Barton et al., 1995) . Southern analysis of the PFGE with DIG-labelled DNA probes encompassing sivA or salA did not detect sivA in either the chromosome or the 190 kbp and 220 kbp plasmids harboured by the bacteriocinogenic S. salivarius strains K12 and JH, respectively (Fig.  3c) . In all three strains, however, each megaplasmid was shown to be probe-positive for SalA by Southern blotting (Fig. 3b) . The restriction enzyme used (SmaI) appeared to linearize the plasmids (i.e. cut the plasmid only once), possibly due to the low G+C content of S. salivarius and the fact that the recognition sequence of SmaI is CCCGGG, making it a rare cutter of S. salivarius DNA -for example, SmaI has only 17 recognition sites in strain JIM8780. This resulted in an increased release of megaplasmid from the agarose plug, which was visualized as a brighter DNA band. These bands were identified as plasmid during the Southern Fig. 4 . MALDI-TOF MS analysis of fractions A and B from HPLC fractionation of strain 9 methanol extracts from spiked culture cells. The mass assigned to the major peak in each fraction is shown. Fraction A corresponds to the mass predicted for Sal9 while the mass in fraction B is equivalent to that of SalA4 previously characterized from S. salivarius strain 9. analysis because they were the same size as the hybridization band in the uncut DNA lanes as indicated by the arrows in lanes 3, 5 and 7 in Fig. 3(b) . Further confirmation of the plasmid location of the Sal9 locus was obtained through curing strain 9 of its megaplasmid resulting in strain 9P 2 , which is both sivA-and salA-negative (Table 1) . By contrast, the Sal9 locus is chromosomally located in strain JIM8780 (as determined by complete genome sequencing), this being to our knowledge the first established example of a lantibiotic locus being other than plasmid-borne in S. salivarius. Flanking the Sal9 locus in strain JIM8780 are incomplete transposase genes which may have provided a mechanism for the movement of the locus within S. salivarius and its insertion between the chromosomally located gtfD and gtfI genes of the glucosyltransferase locus in strain JIM8780 (Fig. 1) .
Distribution of the Sal9 locus
A PCR screen, using the primer pairs sivAF/sivAR (to amplify sivA) and salAF/salAR (to amplify salA), was applied to a selection of S. salivarius strains known to produce various BLIS activities (Table 1) . Twelve (43 %) of the 28 individual strains were positive for sivA, indicating that the Sal9 locus is widespread in BLIS-positive S. salivarius. In addition, 18 (64 %) of the 28 individual strains were positive for SalA and 7 (25 %) of the strains had both sivA and salA. Since salA is widespread in S. pyogenes (Simpson et al., 1995) and sboA (encoding salivaricin B) is present in some Streptococcus mitis strains (Hyink et al., 2007) , 116 S. pyogenes of different M-types and 71 S. mitis strains were screened by Southern hybridization for sivA. None of the strains tested was probe-positive for sivA, indicating that the Sal9 locus may not be commonly (if at all) present in these two oral streptococcal species.
Partial purification of Sal9
Sal9 was purified from methanol extracts of cells of S. salivarius strains 9 and JIM8780 by C18 reversed-phase HPLC. Two separated fractions (A and B) (results not shown) from the strain 9 extract had inhibitory activity against M. luteus and following MALDI-TOF MS analysis the mass of fraction A (2560.6 Da) matched that predicted for Sal9 (Fig. 4a) , whereas the mass of fraction B (2341.6 Da) corresponded to that of SalA4 (Fig. 4b ) . A single inhibitory fraction was obtained from C18 reversed-phase chromatography of strain JIM8780 extract and this also contained a MALDI-TOF MS mass of 2560.6 Da.
Activity spectra of Sal9-producing strains S. salivarius strains 9, M18 (also known as Mia) (Wescombe et al., 2006a) and JIM8780, all of which contain sivA, were tested for inhibitory activity against an extended set of both Gram-positive and Gram-negative indicator bacteria (Table 2) . Inhibitory activity attributable to Sal9 alone appears to be produced by strain JIM8780 and gives the characteristic P-type of 636 (inhibition of 6/9 standard indicators). Both strain 9 and strain M18 also produce variants of SalA and some as yet uncharacterized additional inhibitory agent(s). The inhibitory spectrum of JIM8780 includes strains of S. pyogenes, Lactococcus lactis, Enterococcus hirae, Staphylococcus aureus, Streptococcus uberis and Streptococcus salivarius, indicating that Sal9 production by S. salivarius probiotics such as M18 could potentially contribute more widely to infection control. Sal9 may be especially beneficial when produced by strains also producing SalA and SalB, since the action of multiple bacteriocins serves to reduce the risk of resistance development to the individual bacteriocins in the target Characterization of the lantibiotic salivaricin 9
organisms. Since none of the nine standard indicator strains conventionally used in this laboratory for P-typing of BLIS-positive streptococci appeared specifically to detect Sal9, a separate set of indicator strains was tested for their relative sensitivities to Sal9 and SalA (Table 3 ). The strains S. salivarius H7f and S. salivarius 20P3 (both of which are SalA positive) were inhibited by S. salivarius JIM8780 but not by S. salivarius 20P3, and thus either of these strains could be used to specifically and selectively detect Sal9 (but not SalA) activity.
Specificity of Sal 9 induction
Since other lantibiotics such as SalA have been found to specifically induce their own production (Kuipers et al., 1995; Upton et al., 2001) , crude inhibitor-positive culture extracts from S. salivarius strains 9, JIM8780 and 20P3 (a known SalA producer), as well as inhibitor-positive fractions purified from the crude extracts of strains 9 and JIM8780, were analysed for their ability to induce inhibitor production by S. salivarius strains 9, JIM8780 and 20P3 (Table 4) . Whereas the crude extract from strain 9 was found to induce inhibitor production by both strain 9 and strain 20P3, the purified Sal9 peptide in fraction A only induced inhibitor production in strain 9, while the fraction B peptide (i.e. SalA) induced inhibitor production in both strains. It must be noted, however, that while the Sal9 preparation used appeared to be pure, there have been reports of induction peptides co-purifying with bacteriocins (Diep et al., 1995) and therefore it is possible that a low level of a different molecule may be responsible for the induction observed. Both the crude extract and the purified inhibitory fraction from strain JIM8780 only induced inhibitor production in strains JIM8780 and 9, whereas the crude extract from strain 20P3 induced inhibitor production in both strain 20P3 and strain 9. These results indicate that the predicted molecular conformational differences between the Sal9 and SalA peptides are significant and Sal9 falls outside the requirements for specific recognition by the sensor kinase SalK.
Concluding remarks
It seems evident from their ubiquitous presence in S. salivarius that lantibiotics must play an important ecological role within the microbiota of oral mucosal surfaces. Sal9 with its inhibitory activity against S. pyogenes may prove to be an important lantibiotic in the oral probiotic arena. For example, S. salivarius strain M18 (marketed in the USA) was shown in the present study to encode Sal9 as potentially one of the mechanisms through which it effects improved oral health. In addition, the availability of technology for transfer of S. salivarius megaplasmids to plasmid-free S. salivarius (Wescombe et al., 2006a) now facilitates the tailor-making of designer probiotic strains containing desirable combinations of BLIS armoury, colonization efficiency and immune stimulatory capability. The probiotic potential of S. salivarius should continue to maintain research interest in the further characterization of novel inhibitors produced by this species. 
